<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pragman AA</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NCATS NIH HHS</funding><funding>National Institutes of Health</funding><funding>U.S. Department of Veterans Affairs</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><funding>CSRD VA</funding><pagination>114</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6555967</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study was to determine key features that differentiate the oral and sputum microbiota of FEs from the microbiota of IEs during periods of clinical stability.&lt;h4>Methods&lt;/h4>We recruited 11 FE and 11 IE who had not used antibiotics or systemic corticosteroids in the last 1 month. Subjects provided oral wash and sputum samples, which underwent 16S V4 MiSeq sequencing and qPCR of 16S rRNA. Data were analyzed using Dada2 and R.&lt;h4>Results&lt;/h4>FE and IE were similar in terms of age, FEV&lt;sub>1&lt;/sub> pe</pubmed_abstract><journal>Respiratory research</journal><pubmed_title>Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.</pubmed_title><pmcid>PMC6555967</pmcid><funding_grant_id>UL1 TR002494</funding_grant_id><funding_grant_id>8UL1TR000114; 5KL2TR113</funding_grant_id><funding_grant_id>KL2 TR002492</funding_grant_id><funding_grant_id>IK2 CX001095</funding_grant_id><funding_grant_id>5T32AI055433</funding_grant_id><funding_grant_id>T32 GM108557</funding_grant_id><funding_grant_id>1IK2CX001095</funding_grant_id><pubmed_authors>Knutson KA</pubmed_authors><pubmed_authors>Wendt CH</pubmed_authors><pubmed_authors>Isaacson RE</pubmed_authors><pubmed_authors>Pragman AA</pubmed_authors><pubmed_authors>Reilly CS</pubmed_authors><pubmed_authors>Gould TJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.</name><description>&lt;h4>Background&lt;/h4>Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study was to determine key features that differentiate the oral and sputum microbiota of FEs from the microbiota of IEs during periods of clinical stability.&lt;h4>Methods&lt;/h4>We recruited 11 FE and 11 IE who had not used antibiotics or systemic corticosteroids in the last 1 month. Subjects provided oral wash and sputum samples, which underwent 16S V4 MiSeq sequencing and qPCR of 16S rRNA. Data were analyzed using Dada2 and R.&lt;h4>Results&lt;/h4>FE and IE were similar in terms of age, FEV&lt;sub>1&lt;/sub> pe</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-06-01T12:38:42.08Z</modification><creation>2025-06-01T12:38:42.08Z</creation></dates><accession>S-EPMC6555967</accession><cross_references><pubmed>31174538</pubmed><doi>10.1186/s12931-019-1080-4</doi></cross_references></HashMap>